Contributing to providing insight for immunotherapeutic treatment in THCA, the tumor immune infiltrates of THCA, including B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages and dendritic cells, were analyzed via the TIMER platform. The gene discussed is CD8A; the disease is neoplasm.